Dr Hanson Yu has been awarded the Endolift® Award of Excellence 2026, highlighting his contribution as a specialist in a rapidly advancing field of minimally invasive aesthetic treatments.
The award, presented as part of the Endolift® Achievement Awards, recognises practitioners who maintain a high standard of technical performance, deliver strong patient outcomes and demonstrate careful clinical judgement in the use of Endolift®, a laser-driven procedure aimed at collagen stimulation, tissue tightening and improved skin laxity without surgical intervention.
What sets this recognition apart is its specificity. Rather than focusing solely on the adoption of technology, it assesses how effectively it is used, including decision-making around patient suitability, treatment design and long-term effectiveness.
Developed in Italy, Endolift® has gained significant momentum across European and UK markets as a minimally invasive alternative to surgical lifting. By inserting micro-optical fibres beneath the skin, the procedure delivers controlled laser energy to reshape tissue, reduce small pockets of fat and enhance definition, offering a middle ground between non-invasive and surgical approaches.
However, the quality of results remains highly dependent on the practitioner’s expertise.
Dr Hanson’s recognition reflects a broader change within the aesthetics sector, where the emphasis is shifting away from technology-led marketing towards outcomes driven by clinical skill. In an increasingly competitive landscape, access to devices is no longer the key differentiator; rather, it is the practitioner’s judgement and execution.
Colleagues and observers often highlight Dr Hanson’s structured and cautious methodology. Endolift® is rarely used in isolation, instead forming part of a wider treatment strategy that considers facial anatomy, the ageing process and long-term patient goals.
This approach aligns with an emerging focus within aesthetic medicine on holistic treatment planning and continuity of care, moving beyond one-off procedures.
At the same time, patient expectations are evolving. Greater awareness of safety and results has led to increased demand for treatments that offer noticeable improvements with reduced recovery time and lower risk.
Within this context, Endolift® continues to establish its place, although its effectiveness relies on precise application, depth accuracy and a thorough understanding of tissue behaviour.
The award positions Dr Hanson among a limited group of practitioners recognised for advanced application of the technology. More broadly, it underscores the importance of clinical expertise in achieving reliable and high-quality outcomes, even as innovation continues to shape the industry.
